Search
Browse
- Diseases
- Sponsors
Pipeline Pulse
Watchlist
Blog
Pricing

Sign in

Sponsor pipeline

Incendia Therapeutics

Filter by disease

Loading trials...

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

ImportanceWhat changedUpdated

Minor

PRTH-101 Monotherapy +/- Pembrolizumab · Advanced Malignancies

Trial completed

Also in this update: Final enrollment: 79 participants (planned 270); Primary completion date changed from estimate of Sep 30, 2027 to Sep 2, 2026

Incendia TherapeuticsPhase 1 NCT05753722 Registry history of NCT05753722 on ClinicalTrials.gov (opens the registry)

Sep 28, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Loading therapeutic areas...

Data updated daily from ClinicalTrials.gov.

0 trials selected Compare →

Sign in to save sponsors

Enter your email to receive a login link. No password needed.

Check your email for a login link.

datalookout.com Blog Privacy Terms Cookie settings

© 2026 DataLookout. Data from ClinicalTrials.gov. Not affiliated with the NLM.